Search - tctmd.com

Displaying 441 - 460 of 1277

Sort: Relevancy | Date

News Daily News

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

October 24, 2014

News Daily News

1ª Sustitución de la Válvula Mitral Transcatéter en Humanos Revela Seguridad y Eficacia

Yael L. Maxwell

October 24, 2014

News Daily News

La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR

October 17, 2014

News Daily News

Preexisting Thrombocytopenia Worsens Complications After TAVR

L.A. McKeown

October 16, 2014

News Daily News

La Trombocitopenia Preexistente Empeora las Complicaciones Post-TAVR

L.A. McKeown

October 16, 2014

Presentation VEINS 2014

Role of Supra Renal IVC Filters and SVC Filters

Presenter: Matthew S. Johnson

October 12, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

L.A. McKeown

October 10, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

Heart Block Itself Does Not Worsen Prognosis After AMI

Caitlin E. Cox

October 10, 2014

News Daily News

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

L.A. McKeown

October 10, 2014

News Daily News

El Bloqueo Cardíaco Per Se no Empeora el Pronóstico Post-IAM

Caitlin E. Cox

October 10, 2014

News Daily News

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

October 10, 2014

Presentation VEINS 2014

Renal, Mesenteric, and Aortic Duplex

Presenter: Heather L. Gornik

October 09, 2014

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka

September 16, 2014

Presentation TCT 2014

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud

September 16, 2014

Presentation TCT 2014

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

$Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension$

Presentation TCT 2014

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Steffen Desch

September 16, 2014

Advertisement

La Hiperglucemia Aguda Empeora el Pronóstico Post-IAM

1ª Sustitución de la Válvula Mitral Transcatéter en Humanos Revela Seguridad y Eficacia

La FA Preexistente, No de Reciente Aparición, Predice Peores Resultados a Largo Plazo Post-TAVR

Preexisting Thrombocytopenia Worsens Complications After TAVR

La Trombocitopenia Preexistente Empeora las Complicaciones Post-TAVR

Role of Supra Renal IVC Filters and SVC Filters

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Heart Block Itself Does Not Worsen Prognosis After AMI

El Riesgo de Sufrir ACV y Embolismos Sistémicos es Más Alto cuando Combinamos Amiodarona + Warfarina que Amiodarona +Apixaban

El Bloqueo Cardíaco Per Se no Empeora el Pronóstico Post-IAM

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

Renal, Mesenteric, and Aortic Duplex

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

What Is the Clinical Trial Pathway Moving Forward for Renal Denervation?

Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy

New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Clinical Trial Updates: RenalGuard, AVERT, etc.

Symplicity Flex: A Prospective, Randomized, Sham-Controlled Trial of Renal Sympathetic Denervation in Patients with Mild Refractory Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content